Published Research
1.
D. Zella, A. Cavicchini, M. Salemi, C. Casoli, P. Ferrante, F. Lori, G.
Achilli, E. Cattaneo, V. Landini, and U. Bertazzoni (1993). Molecular
characterization of two isolates of Human T-cell leukemia virus type II
from Italian drug abusers and comparison of genome structure with other
isolates. J. Gen. Virol. 74: 437-444.
2. Lamers SL, JW Sleasman, KA Barrie, SM Pomeroy, DJ
Barrett, and MM Goodenow. Independent Variation and Positive Selection
in env V1 and V2 Domains Within Maternal-Infant Strains of Human
Immunodeficiency Virus Type 1 in vivo. J. Virol. 67:3951-3960, 1993.
3. Lamers, SL., J.W. Sleasman, K.A. Barrie, S.M.
Pomeroy, D.J. Barrett, and M.M. Goodenow. Persistence of Multiple
Maternal HIV-1 Genotypes in Infants Infected by Perinatal Transmission.
J. Clin. Invest. 93:380-390, 1994.
4. M. Salemi, E. Cattaneo, C. Casoli, and U.
Bertazzoni (1995). Identification of IIa and IIb molecular subtypes of
Human T-cell lymphotropic virus type II among Italian injecting drug
users. J. Acquir. Immune Defic. Syndr. 8: 516-520.
5. Barrie, K.A., E. Perez, S.L. Lamers, W.F.
Farmerie, B.M. Dunn, J.W. Sleasman, and M.M. Goodenow. Natural
Variation in HIV-1 Protease, Gag p7 and p6, and Protease Cleavage
Sites Within Gag/Pol Polyproteins: Amino Acid Substitutions in the
Absence of Protease Inhibitors in Mothers and Children Infected by
Human Immunodeficiency Virus Type 1. Virology. 219:407-416. 1996.
6. Lamers S.L., J.W. Sleasman, and M.M.
Goodenow. A Model for Alignments of env V1 and V2 Hypervariable
Domains from Human Immunodefiviency Viruses. Aids Research and Human
Retroviruses. 12:1169-1177, 1996.
7.
M. Salemi, A-M. Vandamme, F. Guano, E. Cattaneo, C. Casoli, and U.
Bertazzoni (1996). Complete nucleotide sequence of the Italian human
T-cell lymphotropic virus type II (HTLV-II) isolate Gu and phylogenetic
identification of a possible origin of South European epidemics. J.
Gen. Virol. 77:1193-1201.
8. Skinner, L.M., S.L. Lamers, J.C. Sanders, M.E.
Eyster, M.M. Goodenow, and M. Katzman. Analysis of a large collection
of natural HIV-1 Integrase Sequence, Including Those From Long-Term
Nonprogressors. J. Acq. Imm. Def. Synd.and Hum. Ret. 19:99-110, 1998.
9. White G.B., A. Pfahnl, S. Haddock, S.L. Lamers,
Robert M. Greenberg, and P. Anderson. Structure of a Putative
Sodium Channel from the Sea Anenome Aiptasia pallida. Invertebrate
Neuroscience 3, 317-326, 1998.
10. M. Salemi, A-M Vandamme, C. Gradozzi, K Van
Laethem, P. Ferrante, G. Taylor, C. Casoli, P. Goubau, J. Desmyter, and
U. Bertazzoni (1998). Evolutionary rate and genetic heterogeneity of
human T-cell lymphotropic virus type II (HTLV-II) using new isolates
from European injecting drug users. J. Mol Evol.. 46:602-611.
11. M. Salemi, S Van Dooren, E Audenaert, E
Delaporte, P. Goubau, J Desmyter, and A-M Vandamme (1998). Two new
Human T-lymphotropic virus type I subtypes in seroindeterminates, a
Mbuti pygmy and a Gabonese, have closest relatives among African STLV-I
strains. Virology 246:277-287
12. M. Van Brussel, M. Salemi, H-F Liu, P; Goubau, J
Desmyter, and A-M Vandamme (1998). The Simian T-lymphotropic
virus STLV-PP1664 from Pan paniscus is distinctly related to
HTLV-2 but differs in genomic organization. Virology 243:366-379.
13. A-M. Vandamme, M. Salemi, Van Brussel, H-F Liu,,
K. Van Laethem, M. Van Ranst, L. Michels, J. Desmyter, and P. Goubau
(1998). African origin of human T-lymphotropic virus type II (HTLV-II)
supported by a new subtype HTLV-IId in Zairean Bambuti Efe pygmies. J.
Virol. 72:4327-4340.
14. H. Ellerbrok, C. Fleischer, M. Salemi, P.
Reinhardt, W-D. Ludwig, A-M. Vandamme, and G Pauli (1998). Sequence
analysis of the first HTLV-I infection in Germany without relations to
endemic areas. AIDS Res. Hum. Retrovir.: 14:1199-1203.
15. A-M Vandamme, M. Salemi, and J Desmyter (1998).
The simian origins of the pathogenic human T-cell lymphotropic virus
type I. Trends Microbiol.: 6:477-483.
16. S. Van Dooren, E. Gotuzzo, M. Salemi, D. Watts,
E. Audenaert, S. Duwe, H. Ellerbrok, R. Grassmann, J. Desmyter, and A-M
Vandamme (1998). Evidence for a Post-Colombian introduction of human
T-cell lymphotropic virus in Latin America. J. Gen. Virol.:
79:2695-2708.
17. M. Van Brussel, M. Salemi, H-F Liu, P. Goubau, J.
Desmyter, and A-M. Vandamme (1999). The discovery of two new divergent
STLVs has implications for the evolution and epidemiology of HTLVs.
Rev. Med. Virol. 9:155-170.
18. M. Salemi, A-M. Vandamme, J.
Desmyter, C. Casoli, and U. Bertazzoni. The origin and evolution of
Human T-cell Lymphotropic virus type II (HTLV-II) and the relationship
with its replication strategy (1999). Gene: 234:11-21.
19. M. Salemi, M. J. Lewis, J. F. Egan, W. W. Hall,
J. Desmyter, and A-M. Vandamme. Different population dynamics and
evolutionary rates of Human T-cell lymphotropic virus type II (HTLV-II)
in injecting drug users compared to in endemically infected Amerindian
and Pygmy tribes (1999). Proc. Natl. Acad. Sci. USA 96:13253-13259.
20. M. Salemi, S. Van Dooren, and A-M. Vandamme.
Origin of human and simian T-cell lymphotropic viruses (1999). AIDS
Reviews 3:131-139.
21. Ping LH, Nelson JA, Hoffman IF, Schock J, Lamers
SL, Goodman M, Vernazza P, Kazembe P, Maida M, Zimba D, Goodenow MM,
Eron JJ Jr, Fiscus SA, Cohen MS, Swanstrom R. Characterization of V3
sequence heterogeneity in subtype C human immunodeficiency virus type 1
isolates from Malawi: underrepresentation of X4 variants. J Virol. 1999
Aug;73(8):6271-81.
22. A.-M. Vandamme, W. W. Hall, M. Lewis, P. Goubau
and M. Salemi. Origin of HTLV-I in South America (2000). Nature Med.
3:232-233.
23. M. Salemi, J. Desmyter, and A-M. Vandamme. Tempo
and mode of human and simian T-lymphotropic virus (HTLV/STLV) evolution
revealed by analyses of full-genome sequences (2000). Mol. Biol. Evol.
3:374-386.
24. J-P. Allain, Y. Dong, A-M. Vandamme, V. Moulton
and M. Salemi. Evolutionary rate and genetic drift of hepatitis C virus
are poorly correlated with the host immune response: studies of
infected donor-recipient clusters (2000). J. Virol. 6:2541-2549.
25. M. J. Lewis, P. Novoa, R. Ishak, M. Ishak, M.
Salemi, A-M. Vandamme, M. K. Kaplan and W. W. Hall. Isolation, cloning,
and complete nucleotide sequence of a phenotypically distinct Brazilian
isolate of Human T-cell lymphotropic virus type 2 (HTLV-2) isolate
(2000). Virology 271:142-154.
26. Perez EP, Rose SL, Peyser B, Lamers SL, Burkhardt
B, Dunn BM, Hutson AD, Sleasman JW, Goodenow MM. Human
Immunodeficiency Virus Type 1 Protease Genotype Predicts Immune and
Viral Responses to Combination Therapy with Protease Inhibitors (Pis)
in PI-Naïve Patients. J. Inf. Diseases 2001;183:579-88
27. M. Salemi, K. Strimmer, W. W. Hall, M. Duffy, E.
Delaporte, S. Mboup, M. Peeters, and A-M. Vandamme. Dating the common
ancestor of SIVcpz and HIV-1 group M and the origin of HIV-1 subtypes
using a new method to uncover clock-like molecular evolution (2001).
FASEB J. 15:267-268.
28. A-M. Vandamme, U. Bertazzoni, M. Salemi.
Evolutionary strategies of Human T-cell lymphotropic virus type II
(HTLV-II) (2000). Gene 261: 171-180.
19. M. Salemi. Controversy on the origin of HIV
(2000). AIDS Reviews 2:119-120.
20. S. Van Dooren, M. Salemi, and A-M. Vandamme.
Dating the origin of the African Human T-cell lymphotropic virus type I
(HTLV-I) subtypes (2001). Mol. Biol. Evol. 18:661-71.
21. M. Salemi. Bioinformatics in Telemedicine
Glossary 3rd eds (2001), European Commission Directorate General, 2001
Working Document, pp. 33-34.
22. S. Van Dooren, M. Salemi, X. Pourrut, M. Peeters,
M. van Ranst, E. Delaporte and A-M. Vandamme. Evidence for a second
simian t-cell lymphotropic virus type 3 in Cercopithecus nictitans from
Cameroon (2001). J. Virol.75,11939-11941.
23. Tuttle, D.L., C.B. Anders, M.J. Acquino-de Jesus,
P.P. Poole, S.L. Lamers, D.R. Briggs, S.M. Pomeroy, L. Alexander,
K.W.C.Peden, W.A. Andiman, J.W. Sleasman, and M.M. Goodenow. Increased
replication by nonsyncytium-inducing HIV-1 isolates in monocyte-derived
macrophages is linked to clinical decline in patients. AIDS Res Hum
Retroviruses. 2002 Mar 20;18(5):353-62.
24. M. Salemi and A-M. Vandamme. Evolutionary
patterns of Hepatitis C virus studied through analysis of full genome
sequences (2002). J. Mol. Evol.: 54, 62-70.
25. N. Shindo, L. C. J. Alcantara, S. Van Dooren, M.
Salemi, M. C. R. Costa, S. Kashima, D. T. Covas, A. Teva, M.
Pellegrini, I. Brito, A-M. Vandamme and B. Galvao-Castro. Human
retroviruses (HIV and HTLV) in Brazilian Indians: seroepidemiological
study and molecular epidemiology of HTLV type 2 isolates. (2002). AIDS
Res. Hum. Retrovir. 18:71-77
26. P. Lemey, M. Salemi, L. Bassit, H. Heuverswyn,
and Anne-Mieke Vandamme. Phylogenetic classification of TT virus groups
based on the N22 region is unreliable (2002). Virus Res.: 85:47-59.
27. M. J. Lewis, N. Sheehy, M. Salemi, A-M. Vandamme,
and W. W. Hall. Comparison of CREB- and NF-kappaB-mediated
transactivation by human T lymphotropic virus type II (HTLV-II) and
type I (HTLV-I) tax proteins (2002). Virology: 295:182-189.
28. V. Courgnaud, M. Salemi, X. Pourrut, E.
Mpoudi-Ngole, B. Abela, P. Auzel, F. Bibollet-Ruche, B. Hahn, A.-M.
Vandamme, E. Delaporte, M. Peeters Characterization of a novel simian
immunodeficiency virus with a vpu gene from greater spot-nosed monkeys
(Cercopithecus nictitans) provides new insights into simian/human
immunodeficiency virus phylogeny (2002). J. Virol. 76:8298-309.
29. M. Duffy, M. Salemi, N. Sheehy, A-M. Vandamme, J.
Hegarty, M. Curry, N. Nolan, D. Kelleher, S. McKiernan, W.W.
Hall. Comparative Rates of Nucleotide Sequence Variation in
the Hypervariable Region of E1/E2 and the NS5b Region of Hepatitis C
Virus in Patients with a Spectrum of Liver Disease Resulting from a
Common Source of Infection (2002). Virology 301:354-364.
30. X. Xia, Z. Xie, M. Salemi, L. Chen, Y. Wang. An
index of substitution saturation and its application (2003). Mol.
Phylogenet. Evol. 26:1-7.
31. P. Lemey, O. G. Pybus, B. Wang, N. K. Saksena, M.
Salemi, A-M. Vandamme. Tracing the origin and history of HIV-2
epidemics (2003). Proc. Natl. Acad. Sci U.S.A.: 100:6588-6592.
32. K. E. Robbins, P. Lemey, O. G. Pybus, H. W.
Jaffe, A. M. Saekhou, T. M. Brown, M. Salemi, A-M. Vandamme, M. L.
Kalish. Characterization of Early U.S. HIV-1 Strains, Dating of the
Introduction of HIV-1 into the U.S. and Estimation of Population
History of the U.S. Epidemic (2003). J. Virol.: 77:6359-6366.
33. M. Salemi, T. De Oliveira, V. Courgnaud, V.
Moulton, B. Holland, S. Cassol, W. M. Switzer, A-M. Vandamme. Mosaic
genomes of the six major Primate lentivirus lineages revealed by
phylogenetic analyses (2003). J. Virol. 77:7202-7213.
34. L. C. Alcantara, N. Shindo, S. Van Dooren, M.
Salemi, M. C. Costa, S. Kashima, D. T. Covas, A-M. Vandamme, B.
Galvao-Castro. Brazilian HTLV type 2a strains from intravenous drug
users (IDUs) appear to have originated from two sources: Brazilian
Amerindians and European/North American IDUs (2003). AIDS. Res. Hum.
Retrovir. 6:519-23.
35. D. Paraskevis, P. Lemey, M. Salemi, M. Suchard,
Y. Van der Peer, A.-M. Vandamme. Analysis of the evolutionary
relationships of HIV-1 and SIVcpz sequences using Bayesian inference:
Implications for the origin of HIV-1 (2003). Mol. Biol. Evol.
20:1986-96.
36. P. Lemey, M. Salemi, B. Wang, M. Duffy, W.W.
Hall, N. Saksena, A-M. Vandamme. Site stripping based on likelihood
ratio reduction is a useful tool to evaluate the impact of
non-clock-like behavior on viral phylogenetic reconstructions (2003).
FEMS Immunol. Med. Microbiol. 39:125-32.
37. de Oliveira T., Susan Engelbrecht, Estrelita
Janse van Rensburg, Michelle Gordon, Karen Bishop, Jan zur Megede,
Susan W. Barnett, Sharon Cassol. Variability at HIV-1 Subtype C
Protease Cleavage Sites: An Indication of Viral Fitness ? Journal of
Virology, 2003, 77(17): 9422-30
38. de Oliveira T, Miller R, Tarin M, Cassol S. An
Integrated Genetic Data Environment (GDE)-Based LINUX Interface for
Analysis of HIV-1 and Other Microbial Sequences. Bioinformatics ,
2003, 19(1): 153-4.
39. Gordon M, de Oliveira T, Bishop K, Coovadia HM,
Madurai L, Engelbrecht S, Janse van Rensburg E, Mosam A, Smith A,
Cassol S.Molecular Characteristics of HIV-1 Subtype C Viruses from
KwaZulu-Natal, South Africa: Implications for Vaccine and
Antiretroviral Control Strategies. Journal of Virology, 2003 ,
77(4): 2587-2599.
40. Soares M, de Oliveira T, Brindeiro R, Diaz R,
Sabino E, Brigido L, Pires I, Morgado M, Dantas M, Barreira D,
Teixeira P, Cassol S, Tanuri A. A Specific subtype C of human
immunodeficiency virus type 1 circulates in Brazil. AIDS, 2003,
17: 11-22.
41. S.L. Lamers, S. Beason, R. Compton, L. Dunlap, M.
Salemi. HIVbase: a PC/Windows-based software offering storage and
querying power for locally held HIV-1 genetic, experimental, and
clinical data (2004). Bioinformatics 20:436-38.
42. M. Salemi, W. M. Fitch, M. Ciccozzi, , M. J.
Ruiz-Alvarez, G. Rezza, M. J. Lewis. SARS-CoV sequence characteristics
and evolutionary rate estimate from maximum likelihood analysis (2004).
J. Virol. 78:1602-03.
43. T. De Oliveira, M. Salemi, M. Gordon, A-M.
Vandamme, E. J. van Rensburg, S. Engelbrecht, A. Smith, S. Cassol.
Codon-Substitutions Models as Indicators of Positive Selection and
Amino Acid Diversification: An Alternative Approach to HIV-1 Vaccine
Development (2004). Genetics 167:1047-58.
44. S. Van Dooren, O. G. Pybus, M. Salemi, H.-F. Liu,
P. Goubau, C. Remondegui, A. Talarmin, E. Gotuzzo, L. C. J. Alcantara,
B. Galvao-Castro, A-M. Vandamme. The low evolutionary rate of Human
T-Cell Lymphotropic Virus type-1 confirmed by analysis of
vertical transmission chains (2004). Mol. Biol. Evol.: 21:603-611.
45. M. Salemi, T. de Oliveira, M. A. Soares, O. G.
Pybus, A. T. Dumans, A-M. Vandamme, A. Tanuri, S. Cassol, W. M. Fitch.
Different epidemic potentials of HIV-1 B and C subtypes (2005). J. Mol.
Evol. 60:598-605.
46. W. M. Switzer, M. Salemi, V. Shanmugam, F. Gao,
M. Cong, C. Kuiken, V. Bhullar, B. Beer, D. Vallet, A. Gautier-Hion, Z.
Tooze, F. Villinger, E.C. Holmes, and W. Heneine. Ancient Co-speciation
of simian foamy viruses and primates (2005). Nature: 434:376-380.
47. M Salemi, S. L. Lamers, S. Yu, T. De Oliveira, W.
M. Fitch, M. S. McGrath. Phylodynamic analysis of human
immunodeficiency virus type 1 in distinct brain compartments provides a
model for the neuropathogenesis of AIDS (2005). J. Virol. 79:11343-52.
48. L. Cali, B. Wang, M. Mikhail, M. J. Gill, B.
Beckthold, M. Salemi, D. A. Jans, S.C. Piller, N. K. Saksena. Evidence
for host-driven selection of the HIV type 1 vpr gene in vivo during HIV
disease progression in a transfusion-acquired cohort (2005). AIDS Res.
Hum. Retrovir. 8:728-233.
49. de Oliveira T and Cassol S. (developers). Scourge
of a Continent: The BioAfrica Website. Science, 2005, 310: 1872.
50. de Oliveira T., K. Deforche, S. Cassol, M.
Salminen, R. Camacho, D. Pavareskevis, C. Seebregts, J. Snoeck, A.M.
VanDamme. The HIV-1 Automated Subtyping Tool. Bioinformatics, 2005 ,21:
3797-3800
51. Doherty RS, de Oliveira T, Seebregts C, Danaviah
S, Gordon M, Cassol S. BioAfrica's HIV-1 Proteomics Resource: Combining
protein data with bioinformatics tools. Retrovirology. 2005, 9;2(1):18
52. L. Campitelli, M. Ciccozzi, M. Salemi, F. Taglia,
S. Boros, I. Donatelli, G. Rezza (2006). H5N1 influenza virus
evolution: a comparison of different epidemics in birds and humans
(2006). J. Gen. Virol. 87:955-960.
53. S. L. Lamers, M. Salemi, M. S. McGrath, G. B.
Fogel. Predicting HIV R5, X4 and Dual tropic phenotype using evolved
neural networks (2006). IEEE/ACM Trans. Comp. Biol. Bioinf.
54. de Oliveira T, Pybus OG, Rambaut A., Salemi M,
Cassol S, Ciccozzi M, Rezza G, Gattinara GC, D'Arrigo R, Amicosante M,
Perrin L, Colizzi V, Perno CF. Molecular Epidemiology of New HIV-1 and
HCV Sequences From Benghazi, Libya. Nature, 2006, in press.
55. de Oliveira T. Out of Africa: The BioAfrica
Website. BioTechniques, 2006, 41(2): 129.
56. Gifford R, de Oliveira, T, Rambaut A, Myers RE,
Gale CV, Dunn D, Shafer R, Vandamme A, Kellam P, and D. Pillay.
Assessment of Automated Genotyping Protocols as Tools for Surveillance
of HIV-1 Genetic Diversity. AIDS, 2006, 20(11):1521-9.
57. Alcantara LC, de Oliveira T, Gordon M, Pybus O,
Mascarenhas RE, Seixas MO, Goncalves M, Hlela C, Cassol S,
Galvao-Castro B.Tracing the origin of Brazilian HTLV-1 as determined by
analysis of host and viral genes.AIDS. 2006, 20(5):780-782.
Bioinformatics
Pricing Structure
List
of
Publications
Currently
funded projects